Metabolic activation of carcinogens and expression of various cytochromes P450 in human prostate tissue

Carcinogenesis

Volumn 21, Issue 9, 2000, Pages 1683-1689

  Williams, J A ^a   Martin, F L ^a   Muir, G H ^b   Hewer, A ^a   Grover, P L ^a   Phillips, D H ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINO 1 METHYL 6 PHENYLIMIDAZO[4,5 B]PYRIDINE; 2 AMINO 3 METHYLIMIDAZO[4,5 F]QUINOLINE; ALPHA NAPHTHOFLAVONE; BENZO[A]PYRENE; CARCINOGEN; CYTOCHROME P450; DNA; ETHOXYRESORUFIN DEETHYLASE; MESSENGER RNA; NUCLEOTIDE; PHENACETIN O DEETHYLASE; PHOSPHORUS 32;

ARTICLE; CARCINOGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; DNA ADDUCT; HUMAN; HUMAN TISSUE; MALE; METABOLIC ACTIVATION; METABOLITE; ORGAN CULTURE; PILOT STUDY; PRIORITY JOURNAL; PROSTATE; PROSTATE CANCER; PROSTATE HYPERTROPHY; PROSTATECTOMY; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA TRANSCRIPTION; TRANSURETHRAL RESECTION;

EID: 0033861941     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/21.9.1683     Document Type: Article

References (54)

1. Well-done meat intake and the risk of breast cancer
2. Diet, alcohol, coffee and pancreatic cancer: Final results from an Italian study
3. Nutrition and pancreatic cancer
4. Heterocyclic amine content of cooked meat and risk of prostate cancer
5. Food heating and the formation of heterocyclic aromatic amine and polycyclic aromatic hydrocarbon mutagen/carcinogens
6. Metabolism of 2-amino-1-methyl-6-phenylimidazol[4,5-b]pyridine by human cytochrome P4501A1, P4501A2 and P4501B1
7. Determination of the enzymes responsible for activation of the heterocyclic amine 2-amino-3-methylimidazo[4,5-f]quinoline in the human breast
8. Metabolic activation and deactivation of arylamine carcinogens by recombinant human NAT1 and polymorphic NAT2 acetyltransferases
9. N-acetyltransferase expression and metabolic activation of the food-derived heterocyclic amines in the human mammary gland
10. Human mammary NAT and SULT enzymes metabolically activate N-hydroxylated heterocyclic amines, but NAT enzyme activity is not influenced by NAT genotype
11. Bioactivation of the cooked food mutagen N-hydroxy-2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine by estrogen sulfotransferase in cultured human mammary epithelial cells
12. Sulfotransferase catalyzing sulfation of heterocyclic amines
13. Mutagenic specificity of 2-amino-3-methylimidazo[4,5-f]quinoline and 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in the supF shuttle vector system
14. DNA adducts of heterocyclic amine food mutagens: Implications for mutagenesis and carcinogenesis
15. Pathways of heterocyclic amine activation in the breast: DNA adducts of 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) formed by peroxidases and in human mammary epithelial cells and fibroblasts
16. Metabolic activation of benzo(a)pyrene proceeds by a diol-epoxide
17. Cancer initiation by polycyclic aromatic hydrocarbons results from formation of stable DNA adducts rather than apurinic sites
18. Normal histology of the prostate
19. Benign prostatic hyperplasia: Characteristics of the disease observed in the general population
20. Benign prostatic tissues express CYP1 and NAT genes and activate potential prostate carcinogens
21. Standardization and validation of DNA adduct post-labelling methods: Report of interlaboratory trials and production of recommended protocols
22. Culture of human prostatic epithelial cells
23. 32P-Post-labelling analysis of non-radioactive aromatic carcinogen DNA adducts
24. Tissue distribution of DNA adducts in CDF1 mice fed 2-amino-3-methylimidazo[4,5-f] quinoline and 2-amino-3,4-dimethylimidazo[4,5-f] quinoline (MeIQ)
25. 32P-post-labelling method to recover IQ-DNA adducts as mononucleotides
26. 32P-post-labelling test for structurally diverse DNA adducts
27. Interindividual variation in the metabolic activation of heterocyclic amines and their N-hydroxy derivatives in primary cultures of human mammary epithelial cells
28. Selectivity of polycyclic inhibitors for human cytochrome P450s 1A1, 1A2 and 1B1
29. Systemic exposure to dietary heterocyclic amines in man
30. Induction of drug-metabolizing enzymes in human pancreatic cancer and chronic pancreatitis
31. Up-regulation of cytochrome P450 1A2, 2C9 and 2E1 in chronic pancreatitis
32. Expression of CYP1A1 and CYP1A2 genes in human liver
33. Pre-translational regulation of cytochrome P450 genes is responsible for disease-specific changes of individual P450 enzymes among patients with cirrhosis
34. Detection of three genetic polymorphisms in the 5'-flanking region and intron 1 of human CYP1A2 in the Japanese population Jpn
35. Functional significance of a C→A polymorphism in intron 1 of the cytochrome P450 CYP1A2 gene tested with caffeine
36. Detailed modelling of caffeine metabolism and examination of the CYP1A2 gene: Lack of a polymorphism in CYP1A2 in Caucasians
37. Characterization of CYP1B1 and CYP1A1 expression in human mammary epithelial cells: Role of the aryl hydrocarbon receptor in polycyclic aromatic hydrocarbon metabolism
38. Induction of CYP isoenzymes in various organs of rats by 3-methylcholanthrene or beta-naphthoflavone
39. Expression of CYP1B1 in human adult and fetal tissues and differential inducibility of CYP1B1 and CYP1A1 by Ah receptor ligands in human placenta and cultured cells
40. The prostate: A target for carcinogenicity of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) derived from cooked foods
41. Arylamine-nucleoside adduct formation: Evidence for arylnitrene involvement in the reactions of an N-acetoxyarylamine
42. WCRF and AICR Food, Nutrition and the Prevention of Cancer: A Global Perspective
43. 32P-post-labeling
44. N-acetyltransferase expression and DNA binding of N-hydroxyheterocyclic amines in human prostate epithelium
45. Human hydroxysteroid sulfotransferase SULT2B1: Two enzymes encoded by a single chromosome 19 gene
46. The identification of [2-(14)C]2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine metabolites in humans
47. Detoxification of carcinogenic aromatic and heterocyclic amines by enzymatic reduction of the N-hydroxy derivative
48. The metabolism of 2-amino-3,8-dimethylimdiazo[4,5-f]quinoxaline in human hepatocytes
49. Cancer risk due to occupational exposure to polycyclic aromatic hydrocarbons
50. Oils and cancer
51. Occupational risk factors and prostate cancer in U.S. blacks and whites
52. Polycyclic aromatic hydrocarbons in the diet
53. Inhibition of human cytochrome P450-catalyzed oxidation of xenobiotics and procarcinogens by synthetic organoselenium compounds